| Application no. and date | 02722625.7 (espacenet) (Federated) (European Patent Register), 20020426 | | Patent/reg. no. and date | DK/EP 1392307, 20050824 | | Publication date | 20040303 | | Priority no. and date | US 290861 P, 20010514 | | EP pub. no. and date |
EP 1392307 20040303 | | Effective date | | | Applicant/owner | Pfizer Products Inc., Eastern Point Road
Groton,
Connecticut 06340, US | | Applicant ref. no. | 124160 | | Inventor | ROSE, Peter Robert,
Pfizer Global R & D, Eastern Point Road
Groton, CT 06340, US,
WILLIAMS, Glenn Robert,
Pfizer Global R & D, Development,
Eastern Point Road
Groton, CT 06340, US,
BOGLE, David Everett,
Pfizer Global R & D, 10 Beaulieu Avenue
Jewett City 06351, US | | Representative | Budde Schou A/S, Dronningens Tværgade 30, 1302 København K | | Opponent | | | IPC Class | A61K 31/495 (2006.01) , A61P 27/00 (2006.01) , A61P 29/00 (2006.01) , C07D 471/08 (2006.01) , C07D 221/00 (2006.01) , C07D 223/00 (2006.01) , C07D 471/08 (2006.01) | | Title | Tartratsalte af 5,8,14-triazatetracyclo[10.3.1.02,11.04,9]-hexadeca-2(11),3,5,7,9-pentaen | | Int. application no. | IB2002001437 | | Int. publication no. | WO2002092089 | | Related patent (certificate) | | | Status | Udløbet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
